Onph target price
WebAccording to . 9 Wall Street analysts that have issued a 1 year PH price target, the average PH price target is $371.89, with the highest PH stock price forecast at $446.00 and the lowest PH stock price forecast at $310.00.On average, Wall Street analysts predict. that Parker Hannifin's share price could reach $371.89 by Mar 6, 2024. WebAssess the Oncology Pharma stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst 12-Month ONPH price …
Onph target price
Did you know?
WebONPH Stock. USD 0.39 0.01 2.50%. Oncology Pharma stock price prediction is an act of determining the future value of Oncology Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Oncology Pharma's future price could yield a significant ... WebFind the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.
Web24 de mar. de 2024 · A. The stock price for Oncology Pharma ( OTCPK: ONPH) is $ 0.18 last updated March 24, 2024, 12:55 PM PDT. Q. WebHá 2 dias · On average, they expect the price of ether to hit $19,842 by 2025. The majority of panelists say now is the time to buy ethereum while 28% say to hodl. Experts See Price of Ether Reaching Almost ...
WebFundamentals. Advice. Buy or Sell Calendar Exposure. ONPH Stock. USD 0.39 0.01 2.50%. Analysts of Oncology Pharma render investment recommendations by dissecting financials, analyzing earning calls, and talking to Oncology Pharma vendors, executives, and customers to validate their buy-or-sell advice. Unfortunately, the analyst consensus on ... WebTop Stocks in Biotechnology. Inozyme Pharma Inc. 89bio Inc. Immuneering Corporation. 435 Merchant Walk Square, Suite 300-145. Charlottesville, VA 22902. US: +1 800 698 9101. International: +1 434 293 9100.
Web17 de jul. de 2024 · Get The Latest ONPH Stock Forecast, Price Target, and Headlines at MarketBeat. Should You Buy or Sell Oncology Pharma Stock? Get The Latest ONPH Stock Forecast, Price Target, and Headlines at MarketBeat. Skip to main content. S&P 500 … Is Oncology Pharma (OTCMKTS:ONPH) the best stock in the Prepackaged … View breaking ONPH news today from trusted media outlets at MarketBeat. … Price Target N/A. Profile. Chart. Competitors. Headlines. Short Interest. … Get The Latest HCMC Stock Forecast, Price Target, and Headlines at … 2 brokerages have issued 12-month price objectives for CareCloud's stock. Their … Their DCTH share price forecasts range from $14.00 to $19.00. On average, … Price Target and Rating. Average Stock Price Forecast $4.83. High Stock Price … Should You Buy or Sell Cocrystal Pharma Stock? Get The Latest COCP Stock …
WebFind the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing. simple church directory appWeb15 de out. de 2024 · Aerovate Therapeutics Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $24.67. Aerovate Therapeutics Inc next reports earnings on November 14. -CureVac BV ( CVAC) stock is trading at $39.94, a decline of $5.53, or 12.76%, on … simple church fairfieldWeb3 de set. de 2024 · long ONPH penny stocksseems like it reached it bottom. a lot of volume came in in the past two months little by little right after it hits its lowest price. i longed at 0.0695 target A $.10 target B $0.16 penny stocksseems like it reached it bottom. a lot of volume came in in the past two months little by little right after it hits its lowest ... raw cabbage and weight lossWeb17 de mar. de 2024 · Get the latest Price and Consensus Chart for Oncology Pharma from Zacks Investment Research ONPH: Oncology Pharma - Price & Consenus Chart - … raw cacao chocolate candy recipeWeb22 de mar. de 2024 · It was only last year that the investment management company set a $7,000 per share price target on Tesla by 2024-- now $1,400 after the automaker's 5-for-1 stock split last summer. raw cabbage and dogsWebOncology Pharma entered into a Licensing Agreement with NanoSmart®Pharmaceuticals Inc. for its "novel" drug delivery platform that can target many types of cancer and other diseases. One of the keys to NanoSmart's® platform technology is a “patented”(US 7,799,327 and EU 1706145 B1) human-derived, antinuclear antibody (ANA) that targets … simple church facebookWebFundamentals. Advice. Buy or Sell Calendar Exposure. ONPH Stock. USD 0.39 0.01 2.50%. Analysts of Oncology Pharma render investment recommendations by dissecting … raw cabinet supplier